About
Small molecules, peptide
Areas of Focus
Categories
Small Molecule PharmaceuticalGene Therapy, RNA & Peptide TherapySan Diego & Southern California
Team (16)
Clinical Trials (12)
View allTotal Trials
12
As Lead Sponsor
11
As Collaborator
1
Total Enrollment
12,355
By Phase
PHASE3: 2PHASE2: 4PHASE1: 4
By Status
COMPLETED: 10NOT_YET_RECRUITING: 1RECRUITING: 1
Clinical Trials Pipeline12 trials
Early Phase 1
Phase 1
Phase 2
Phase 3
Phase 4
Phase 1/2
Phase 2/3
N/A
2002
2003
2004
2005
2006
2007
2008
2009
2010
2011
2012
2013
2014
2015
2016
2017
2018
2019
2020
2021
2022
2023
2024
2025
2026
2027
2028
Today
Hover over trial bars to see details
Recent Trials
NCT07159763Lead Sponsor
A Study to Evaluate the Safety and Efficacy of CD388 for Prevention of Influenza
PHASE3Not yet recruiting
5,500 participants
Started: Sep 30, 2025 · Completed: Jan 31, 2027
NCT06609460Lead Sponsor
Study of CD388 for the Prevention of Influenza in Subjects Not at Risk for Influenza Complications
PHASE2Completed
5,071 participants
Started: Sep 20, 2024 · Completed: Sep 19, 2025
NCT05619536Lead Sponsor
Study of CD388 Subcutaneous Administration in Healthy Japanese Subjects
PHASE1Completed
28 participants
Started: Oct 18, 2022 · Completed: Jul 14, 2023
NCT05523089Lead Sponsor
The Effectiveness of CD388 to Prevent Flu in an Influenza Challenge Model in Healthy Adults
PHASE2Completed
59 participants
Started: Sep 9, 2022 · Completed: Jul 17, 2023
NCT05285137Lead Sponsor
Study of CD388 Intramuscular or Subcutaneous Administration in Healthy Subjects
PHASE1Completed
77 participants
Started: Mar 14, 2022 · Completed: Oct 27, 2023
Locations (1)
Headquarters
San Diego, CA, United States
Map
Loading map...